Cell Toxicity Assay for Dose Response and Viability Analysis
Drug development is a resource-intensive process, with safety representing the primary barrier to market entry. Identifying toxic liabilities early via quantitative cellular health assessments reduces late-stage failure risks and optimizes R&D investment. This article examines technical methodologies for cell toxicity assays, specifically dose-response and viability analysis within regulatory frameworks. We explore how these in vitro …